Monday, Jul 20, 2020 | 4:00 PM ET
Rearchitecting the Drug Launch Model
Manisha Shetty GulatiChief Growth Officer, Commure
Bhash ParasuramanBU Lead of Global Health and Value, Rare Diseases Business, Pfizer
HLTH Content Director, Jody Tropeano interviews Manisha Gulati, Chief Operating Officer, Clarify Health and Bhash Parasuraman, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer . They both recently presented on a HLTH GoLIVE series webinar called “Rearchitecting the drug launch model.” The discussion zeroed in on the incentives of regulators, payers, providers, and patients, which are often at odds with each other when it comes to drug launches.
You May Also Enjoy